Muraglitazar - CISMeF

Preferred Label : Muraglitazar;

NCIt definition : A dual peroxisome proliferator-activated receptor (PPAR) agonist, with hypoglycemic activity. Muraglitazar causes an increase in HDL-C levels, and a decrease in total cholesterol, apolipoprotein B, triglycerides and HbA1c. This agent is associated with an increased risk of adverse cardiovascular events and heart failure.;

UNII : W1MKM70WQI;

InChIKey : IRLWJILLXJGJTD-UHFFFAOYSA-N;

CAS number : 331741-94-7;

Chemical formula : C29H28N2O7;

Détails

Origin ID

C75190;

UMLS CUI

C1568490;

Currated CISMeF NLP mapping
- muraglitazar [MeSH concept]
- muraglitazar [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- muraglitazar [MeSH concept]
- muraglitazar [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients